Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP). (Q42171606)
Jump to navigation
Jump to search
scientific article published on November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP). |
scientific article published on November 2004 |
Statements
1 reference
Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP). (English)
1 reference
George G Zhanel
1 reference
Ayman M Noreddin
1 reference
Theodore K Marras
1 reference
Kevin Sanders
1 reference
Charles K N Chan
1 reference
Daryl J Hoban
1 reference
1 November 2004
1 reference
1 reference
Identifiers
1 reference